Cite

    Iida, K. et al. (n.d.). Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder. Coronary artery disease. 28 (7), p. . [Online].